Association of testosterone deficiency and insulin resistance with prostate cancer severity in patients with type 2 diabetes mellitus

Background. In patients with type 2 diabetes mellitus, insulin resistance and testosterone deficiency may interact to accelerate and worsen prostate cancer. The purpose of the study was to examine the correlation between testosterone deficiency and insulin resistance with the extent of prostate cancer in individuals with type 2 diabetes mellitus and to test whether the two are potential predictive biomarkers of disease progression. Materials and methods. The case-control study was carried out between January 2025 and February 2026 in Iraqi specialized clinics to determine the relationship between testosterone deficiency and insulin resistance and the severity of prostate cancer in patients with type 2 diabetes mellitus. One hundred and fifty individuals (100 patients and 50 controls) were involved. Clinical, biochemical and histopathological criteria were used to diagnose it. Blood samples were taken and biochemical, hormonal indices and insulin resistance were measured by enzyme-linked immunosorbent assay and automated analyzers. Results. The age and smoking status did not show any significant differences whereas body mass index, waist circumference, blood pressure, family history and physical inactivity significantly increased in patients. Metabolic and endocrine changes were lower testosterone and high glucose, insulin, HOMA-IR, glycated hemoglobin, prostate specific antigen, and dyslipidemia (p < 0.001). The severity of the disease was linked to the reduction in testosterone and the rise in the metabolic markers (p < 0.001). There was a strong correlation and regression, which validated testosterone deficiency and insulin resistance as important predictors of prostate cancer severity in patients with type 2 diabetes mellitus. Conclusions. Testosterone deficiency and insulin resistance interact to increase the severity of prostate cancer in type 2 diabetes mellitus patients, probably because of insulin-like growth factor-1 signaling, chronic inflammation, and hormonal imbalance, which facilitate tumor growth, metabolic dysregulation, and further progression to more aggressive disease phenotypes.

Authors

Institutions

Publication Details

Journal
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Published
2026-11-14
DOI
https://doi.org/10.22141/2224-0721.22.7.2026.1783
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of testosterone deficiency and insulin resistance with prostate cancer severity in patients with type 2 diabetes mellitus

Fatima MOHAMMED, Zainab M. Qassam, Osama Akram Mohsein, Aya Khudhair Khalaf
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Prostate Cancer Treatment and Research
article

Association of testosterone deficiency and insulin resistance with prostate cancer severity in patients with type 2 diabetes mellitus

Fatima MOHAMMED, Zainab M. Qassam, Osama Akram Mohsein, Aya Khudhair Khalaf
article en

Abstract

Background. In patients with type 2 diabetes mellitus, insulin resistance and testosterone deficiency may interact to accelerate and worsen prostate cancer. The purpose of the study was to examine the correlation between testosterone deficiency and insulin resistance with the extent of prostate cancer in individuals with type 2 diabetes mellitus and to test whether the two are potential predictive biomarkers of disease progression. Materials and methods. The case-control study was carried out between January 2025 and February 2026 in Iraqi specialized clinics to determine the relationship between testosterone deficiency and insulin resistance and the severity of prostate cancer in patients with type 2 diabetes mellitus. One hundred and fifty individuals (100 patients and 50 controls) were involved. Clinical, biochemical and histopathological criteria were used to diagnose it. Blood samples were taken and biochemical, hormonal indices and insulin resistance were measured by enzyme-linked immunosorbent assay and automated analyzers. Results. The age and smoking status did not show any significant differences whereas body mass index, waist circumference, blood pressure, family history and physical inactivity significantly increased in patients. Metabolic and endocrine changes were lower testosterone and high glucose, insulin, HOMA-IR, glycated hemoglobin, prostate specific antigen, and dyslipidemia (p < 0.001). The severity of the disease was linked to the reduction in testosterone and the rise in the metabolic markers (p < 0.001). There was a strong correlation and regression, which validated testosterone deficiency and insulin resistance as important predictors of prostate cancer severity in patients with type 2 diabetes mellitus. Conclusions. Testosterone deficiency and insulin resistance interact to increase the severity of prostate cancer in type 2 diabetes mellitus patients, probably because of insulin-like growth factor-1 signaling, chronic inflammation, and hormonal imbalance, which facilitate tumor growth, metabolic dysregulation, and further progression to more aggressive disease phenotypes.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)Vol. 22(7)
Ministry of Health (IQ), University of Diyala (IQ)
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon